Top Markets
#1 B3 (Base) B3 (Base) +14.17%
#2 Janction Janction +12.47%
#3 DMT-NAT DMT-NAT +11.90%
#4 Fake World Assets Fake World Assets +11.22%
#5 TENDIES TENDIES +6.21%
#6 Status Status +4.85%
#7 GoPlus Security GoPlus Security +4.76%
#8 龙虾 (Lobster) 龙虾 (Lobster) +4.30%
#9 Provenance Blockchain Provenance Blockchain +3.88%
#10 Everything Everything +3.72%
Coin of the day
B3 (Base) B3 (Base)
Settings
Language
ENGLISH
Currency
USD
Theme
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Rank in Stocks #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Share Price
$0.617
Last synced: 2024-10-14
Market Cap
$6.13M
Change (1 day)
0.49%
Change (1 year)
0.00%
Country
US
Trade Kineta, Inc. (KA)

Category

Healthcare
P/S ratio for Kineta, Inc. (KA)
P/S ratio as of August 2026 TTM: 0.00
According to Kineta, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00. At the end of 2023 the company had a P/S ratio of 7.37.
P/S ratio history for Kineta, Inc. from 2015 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 0.00 -100.00%
2024 0.00 -100.00%
2023 7.37 -53.96%
2022 16.02 516.56%
2021 2.60 -12.26%
2020 2.96 -83.64%
2019 18.09 -46.90%
2018 34.07 58.35%
2017 21.52 1.10%
2016 21.28 -28.43%
2015 29.74 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE